Skip to content

Estimation of Socioeconomic Burden of Adult Attention-Deficit/Hyperactivity Disorder (ADHD) in Japan

Estimation of Socioeconomic Burden of Adult Attention-Deficit/Hyperactivity Disorder (ADHD) in Japan - Socioeconomic costs of adult ADHD in Japan.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000051654
Enrollment
1800
Registered
2023-07-20
Start date
2023-07-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Attention-Deficit/Hyperactivity Disorder (ADHD)

Interventions

None listed

Sponsors

Takeda Pharmaceutical Company Limited.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: web-based questionnaire Survey -Those who were willing to participate in the survey, understood the contents of the informed consent form for the survey, and gave consent to participation in the survey -Male or female patients >= 18 to < 65 years of age at the time of informed consent. -The subject are living in Japan at the time of the questionnaire. Inclusion criteria for each study population are as follows: -Adult ADHD patients: individuals who have diagnosis of ADHD -Adult families of adult ADHD patients: individuals who do not have diagnosis of ADHD, family members living together are diagnosed with ADHD and aged 18 years or older. -ASRS-positive non-ADHD adults: individuals who do not have diagnosis of ADHD, family members living together have not been diagnosed with ADHD, and ASRS*-positive(>= 4)** -ASRS-negative non-ADHD adults: individuals who do not have diagnosis of ADHD, family members living together have not been diagnosed with ADHD, and ASRS negative(< 4) **At least 4 out of 6 questions about symptom frequency in Part A of the Japanese version of the Adult ADHD Self-Report Scale (ASRS, v1.1) are above the prespecifi edcriteria. Database analysis -Patients diagnosed with 'other mental and behavioral disorders' (including ADHD), and having a health insurance claim in the JMDC database -Patients registered in the JMDC database for the year to be analysed -For ADHD, the patients aged >= 18 and < 65 years in the year to be analysed

Exclusion criteria

Exclusion criteria: A web-based questionnaire Survey -Not applicable Database analysis -Not applicable

Design outcomes

Primary

MeasureTime frame
Socioeconomic Burden of Adult ADHD The costs of medical care, social security services, and productivity loss (the cost of lost employment, reduced salary and reduced work productivity defined by absenteeism and presenteeism) in adult ADHD patients and productivity loss in adult families of adult ADHD patients and their aggregate values are estimated.

Countries

Japan

Contacts

Public ContactYasushi Kawakita

Takeda Pharmaceutical Company Limited. Japan Medical Office

yasushi.kawakita@takeda.com03-3278-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026